Abacavir

Common brands: Abacavir, Epivir, Lamivudine, Ziagen, Norvir

Top reporter: Viiv Healthcare Company

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Protease Inhibitor [EPC]Cytochrome P450 3A Inhibitor [EPC]Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
9,609
Total Reports
3,283
Serious Reports
1,172
Death Reports
30
Reported Reactions
Death Report Ratio: High (12.20%)

Patient Demographics

Male
4,879
Female
2,851

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Abacavir.

# Reaction Reports % of Total
1 PAIN 860
5.8%
2 PYREXIA 841
5.7%
3 NAUSEA 640
4.3%
4 RASH 585
4.0%
5 VOMITING 568
3.9%
6 OFF LABEL USE 555
3.8%
7 EXPOSURE DURING PREGNANCY 542
3.7%
8 FATIGUE 538
3.7%
9 HEPATIC ENZYME INCREASED 536
3.6%
10 HYPERTENSION 531
3.6%
11 HEADACHE 521
3.5%
12 HYPERSENSITIVITY 496
3.4%
13 DRUG INTERACTION 487
3.3%
14 VIROLOGIC FAILURE 486
3.3%
15 TREATMENT FAILURE 484
3.3%
16 ANXIETY 474
3.2%
17 EMOTIONAL DISTRESS 465
3.2%
18 DRUG INEFFECTIVE 442
3.0%
19 FOETAL EXPOSURE DURING PREGNANCY 438
3.0%
20 RENAL FAILURE 437
3.0%
21 THROMBOCYTOPENIA 423
2.9%
22 ANHEDONIA 412
2.8%
23 DIARRHOEA 402
2.7%
24 CHRONIC KIDNEY DISEASE 385
2.6%
25 ANAEMIA 372
2.5%
26 RENAL IMPAIRMENT 361
2.5%
27 HYPERHIDROSIS 360
2.4%
28 PATHOGEN RESISTANCE 360
2.4%
29 PRODUCT USE ISSUE 359
2.4%
30 VIRAL MUTATION IDENTIFIED 356
2.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.